Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

13.83
+1.209.50%
Post-market: 13.81-0.0217-0.16%19:39 EDT
Volume:3.68M
Turnover:50.61M
Market Cap:1.09B
PE:6.53
High:14.19
Open:13.09
Low:13.01
Close:12.63
52wk High:17.29
52wk Low:5.70
Shares:78.65M
Float Shares:72.22M
Volume Ratio:2.42
T/O Rate:5.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.12
EPS(LYR):1.87
ROE:82.56%
ROA:2.29%
PB:4.69
PE(LYR):7.40

Loading ...

PagerDuty publishes investor presentation on Q1 FY2027 performance and AI-first operations strategy

Reuters
·
May 29

PagerDuty Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Lifts Fiscal 2027 EPS Guidance; Shares Gain After-Hours

MT Newswires Live
·
May 29

PagerDuty announces $100M buyback

TIPRANKS
·
May 29

PagerDuty up 13% at $8.40 after Q1 results, guidance raise

TIPRANKS
·
May 29

PagerDuty Q1 revenue inches up; co names John DiLullo as CEO

Reuters
·
May 29

PagerDuty Shares Rise 15% After the Bell Following Results, Outlook

THOMSON REUTERS
·
May 29

PagerDuty Outlook FY Revenue USD 488.5-496.5 Million

THOMSON REUTERS
·
May 29

PagerDuty swings to FY27 Q1 profit of $10.2 million; revenue rises 1% year over year to $121 million

Reuters
·
May 29

PagerDuty Q1 Adj. EPS $0.32 Beats $0.25 Estimate, Sales $120.967M Beat $119.602M Estimate

Benzinga Earnings
·
May 29

PagerDuty Outlook Q2 Adj EPS $0.29 - $0.31

THOMSON REUTERS
·
May 29

PagerDuty - Appoints John Dilullo as CEO; Jennifer Tejada Transitions to Executive Chair

THOMSON REUTERS
·
May 29

PagerDuty - Announces $100 Mln Share Repurchase Program

THOMSON REUTERS
·
May 29

PagerDuty Outlook Q2 Total Revenue of $122.0 Mln - $124.0 Mln

THOMSON REUTERS
·
May 29

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 28

Supernus Pharmaceuticals to Participate in June Investor Conferences

GlobeNewswire
·
May 28

Annovis Bio Regains NYSE Listing Compliance

GlobeNewswire
·
May 26

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

GlobeNewswire
·
May 26

Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

GlobeNewswire
·
May 22

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

GlobeNewswire
·
May 22

PagerDuty Executive Chair Jennifer Tejada disposes of common shares worth $3,227,879.12

Reuters
·
May 21